|
Matthew Bonam, Pharmaceutical Projects Director at AstraZeneca and Tim Davis, chief executive of Exco InTouch discuss their collaboration and the virtues of mHealth in combatting chronic obstructive pulmonary disease.
Tim White, Global Director of Customer Interaction at Lundbeck (formally of Novartis) spoke at this year’s eyeforpharma Barcelona conference and asked a very simple question: ‘How do you successfully implement a digital campaign that serves both regional and global audiences?’
“If a company isn’t online it’s missing out on an opportunity to engage with a significant portion of its audience, who are less likely to find this brand,” says Patricia Nettleship, the Director for Social Media and Influence at UCB.
Emma has set me the task of blogging about “what real-world research does”, and crucially how patients can benefit from the pharma industry using real-world research.
In the rapidly changing world of today, companies are facing major challenges when it comes to not only R&D, technology, and global and local markets, but also the social, environmental and legal context.
I’ve been watching, encouraging, praising and, on occasion, remonstrating about the way pharma do, half-do or don’t do social media for 5 years now.
I first met Emma on a cold November day in 2009 at a rather rubbish pub in Waterloo train station. She was interviewing me about my role as Head of Professional Relations for Sanofi Diabetes UK and Ireland.
A few years ago social media appeared as a new communication channel that was taking the world by storm. Organisations, particularly in consumer goods, saw the huge opportunity it presented and started to actively engage using the channel.
Ever since I began, 25 years ago, to want to raise the profile of my rare disease – adrenomyeloneuropathy (AMN) - I’ve been perplexed about how to have a meaningful conversation with a pharma company.
Matthew Bonam, Pharmaceutical Projects Director at AstraZeneca and Tim Davis, chief executive of...
Tim White, Global Director of Customer Interaction at Lundbeck (formally of Novartis) spoke at this...
“If a company isn’t online it’s missing out on an opportunity to engage with a significant portion...
